Table 3.

Comparison of the changes in hemoglobin A1c in the doubled and switched groups

	Doubled group	Switched group	P value
HbA1c at baseline (%)	7.1 ± 0.7	7.1 ± 0.7	0.981
HbA1c at week 24 (%)	7.5 ± 0.9	7.6 ± 1.0	0.871
Change in HbA1c (%) from baseline to week 24	0.4 ± 0.4	0.5 ± 0.6	0.818

Data are expressed as mean ± SD. The doubled group included patients whose rosuvastatin dose was doubled from 2.5 to 5 mg/day (n = 12). The switched group included patients whose treatment was switched from another statin to 5 mg/day rosuvastatin (n = 33)

SD standard deviation